New painkiller aims to ease Post-Surgery pain without opioid risks

NCT ID NCT06901830

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This phase 2 trial tests an experimental painkiller called YZJ-4729 in people experiencing moderate to severe pain after orthopedic surgery. Participants receive either YZJ-4729, morphine, or a placebo through an IV, and researchers measure pain relief over 48 hours. The goal is to see if YZJ-4729 works well and is safe compared to standard treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
YZJ-4729 tartrate injection
What this could lead to
If successful, YZJ-4729 could offer a new option for managing acute pain after surgery, potentially with fewer side effects than morphine.
What could go wrong
This is an early phase 2 trial with only 150 participants, so results may not apply to everyone. The drug may not work better than existing treatments or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chengdu Second People's Hospital

    Chengdu, China

  • Dalian University Affiliated Zhongshan Hospital

    Dalian, China

  • Dongguan People's Hospital

    Dongguan, China

  • Henan Provincial People's Hospital

    Zhengzhou, China

  • Jinhua Central Hospital

    Jinhua, China

  • Mianyang Central Hospital

    Mianyang, China

  • Ningbo Medical Center Lihuili Hospital

    Ningbo, China

  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, China

  • Shanghai First People's Hospital

    Shanghai, China

  • Sichuan Provincial People's Hospital

    Chengdu, China

  • Suzhou University Affiliated Second Hospital

    Suzhou, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • The First Affiliated Hospital of Ningbo University

    Ningbo, China

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

  • The First Hospital of Jilin University

    Ch’ang-ch’un, China

  • The Second Affiliated Hospital of Fujian Medical University

    Quanzhou, China

  • The Second People's Hospital of Hefei

    Hefei, China

  • The Third Hospital of Hebei Medical University

    Shijiazhuang, China

  • The Third People's Hospital of Chengdu

    Chengdu, China

  • The Third Xiangya Hospital of Central South University

    Changsha, China

  • Zhongda Hospital Southeast University

    Nanjing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.